Prosecution Insights
Last updated: April 19, 2026

Examiner: MONDESI, ROBERT B

Tech Center 1600 • Art Units: 1645 1652

This examiner grants 29% of resolved cases

Performance Statistics

29.3%
Allow Rate
-30.7% vs TC avg
109
Total Applications
+9.0%
Interview Lift
1256
Avg Prosecution Days
Based on 82 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
21.7%
§102 Novelty
22.8%
§103 Obviousness
36.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18031861 METHODS FOR TREATING CERVICAL DYSTONIA Final Rejection REVANCE THERAPEUTICS, INC.
17761126 KETOREDUCTASE POLYPEPTIDES AND POLYNUCLEOTIDES Final Rejection Codexis, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month